Skip to main content
. 2012 Mar 5;5:27–42. doi: 10.4137/CMAMD.S7371

Figure 5.

Figure 5

Indirect comparison of serious adverse events of tocilizumab and other biologics in RA.

Notes: Indirect comparison of serious adverse events of biologics (tocilizumab vs. 8 other biologics and placebo).87 The safety profile of tocilizumab is comparable to other biologics except abatacept and anakinra.